Dechra Pharmaceuticals PLC Director/PDMR Shareholding (8906E)
October 23 2018 - 3:42AM
UK Regulatory
TIDMDPH
RNS Number : 8906E
Dechra Pharmaceuticals PLC
23 October 2018
23 October 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 22 October 2018,
Richard Cotton exercised a nil cost option over ordinary shares of
1p each in the Company. The option was granted to him on 7 March
2017 as part of the recruitment award referred to in the Company's
Directors' Remuneration Report for the year ended 30 June 2018.
The exercise of the option was subject to a performance review,
as a result of which the vesting percentage is 100%.
Name Capacity Number of share Total beneficial Percentage
over which option shareholding of issued
exercised following this share capital
announcement
Richard
Cotton Director 21,033 63,384 0.062%
The Notification of Dealing Form set out below is provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Richard Cotton
---------------------------------- --------------------------------------------
2. Reason for the notification
--------------------------------------------------------------------------------
a) Position/status Director/PDMR
---------------------------------- --------------------------------------------
b) Initial notification/ Initial Notification
amendment
---------------------------------- --------------------------------------------
3. Details of the Issuer
--------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
---------------------------------- --------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
---------------------------------- --------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
--------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
---------------------------------- --------------------------------------------
b) Nature of the Exercise of an option granted as part
transaction of a recruitment award to acquire 21,033
shares
---------------------------------- --------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPNil Cost 21,033
---------------------------------- ------------------------- -----------------
d) Aggregated information
* Aggregate volume
N/A
* Price
---------------------------------- --------------------------------------------
e) Date of the transaction 2018.10.22
---------------------------------- --------------------------------------------
f) Place of the transaction Outside a trading venue
---------------------------------- --------------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFKNDNFBDKFKB
(END) Dow Jones Newswires
October 23, 2018 04:42 ET (08:42 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024